Gene therapy holds the promise of preventing and curing disease by manipulating gene expression within a patient's cells.
Red Nucleus is doubling down on health economics and outcomes research (HEOR) as payer scrutiny, pricing pressure and ...
Following Nucleus RadioPharma’s 2022 debut, the GE HealthCare- and Mayo Clinic-backed radiopharmaceuticals CDMO is ready to put its production thesis to the test. Nucleus on Tuesday revealed that it ...
An increasing number of organizations are adopting microservices, the loosely coupled, independently deployable services that together make up an app. According to a 2020 O’Reilly survey, 77% of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results